Opus Genetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Opus Genetics and other ETFs, options, and stocks.

About IRD

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders.

CEO

George Magrath

CEOGeorge Magrath

Employees

Employees18

Headquarters

Durham, North Carolina

HeadquartersDurham, North Carolina

Founded

2018

Founded2018

Employees

Employees18

IRD Key Statistics

Market cap

58.00M

Market cap58.00M

Price-Earnings ratio

-0.48

Price-Earnings ratio-0.48

Dividend yield

—

Dividend yield—

Average volume

227.41K

Average volume227.41K

High today

$0.98

High today$0.98

Low today

$0.9103

Low today$0.9103

Open price

$0.9211

Open price$0.9211

Volume

243.01K

Volume243.01K

52 Week high

$2.18

52 Week high$2.18

52 Week low

$0.65

52 Week low$0.65

People also own

Based on the portfolios of people who own IRD. This list is generated using Robinhood data, and it’s not a recommendation.